Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tüting

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Nature|January 5, 2017
Genome-wide in vivo screen identifies novel host regulators of metastatic colonizationLouise van der Weyden, Mark J Arends, Andrew D Campbell, et al.
Nature Medicine|November 4, 2008
5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanomaHendrik Poeck, Robert Besch, Cornelius Maihoefer, et al.
Chemistry & Biology|July 19, 2014
A cell-permeable inhibitor to trap Gαq proteins in the empty pocket conformationAnna-Lena Schmitz, Ramona Schrage, Evelyn Gaffal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant TreatmentClaus Garbe, Ulrike Keim, Teresa Amaral, et al.
Nature|February 28, 2014
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanomaTobias Bald, Thomas Quast, Jennifer Landsberg, et al.
Nature|June 14, 2023
CD4<sup>+</sup> T cell-induced inflammatory cell death controls immune-evasive tumoursBastian Kruse, Anthony C Buzzai, Naveen Shridhar, et al.
Cancers|February 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant MelanomaMichael Weichenthal, Dirk Debus, Lisa Zimmer, et al.
Immunity|October 19, 2017
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer ImmunotherapyNicole Glodde, Tobias Bald, Debby van den Boorn-Konijnenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patientsSelma Ugurel, Nessr Abu Rached, Thilo Gambichler, et al.
Nature Communications|December 15, 2015
The experimental power of FR900359 to study Gq-regulated biological processesRamona Schrage, Anna-Lena Schmitz, Evelyn Gaffal, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Nature|January 5, 2017
Genome-wide in vivo screen identifies novel host regulators of metastatic colonizationLouise van der Weyden, Mark J Arends, Andrew D Campbell, et al.
Nature Medicine|November 4, 2008
5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanomaHendrik Poeck, Robert Besch, Cornelius Maihoefer, et al.
Chemistry & Biology|July 19, 2014
A cell-permeable inhibitor to trap Gαq proteins in the empty pocket conformationAnna-Lena Schmitz, Ramona Schrage, Evelyn Gaffal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant TreatmentClaus Garbe, Ulrike Keim, Teresa Amaral, et al.
Nature|February 28, 2014
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanomaTobias Bald, Thomas Quast, Jennifer Landsberg, et al.
Nature|June 14, 2023
CD4<sup>+</sup> T cell-induced inflammatory cell death controls immune-evasive tumoursBastian Kruse, Anthony C Buzzai, Naveen Shridhar, et al.
Cancers|February 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant MelanomaMichael Weichenthal, Dirk Debus, Lisa Zimmer, et al.
Immunity|October 19, 2017
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer ImmunotherapyNicole Glodde, Tobias Bald, Debby van den Boorn-Konijnenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patientsSelma Ugurel, Nessr Abu Rached, Thilo Gambichler, et al.
Nature Communications|December 15, 2015
The experimental power of FR900359 to study Gq-regulated biological processesRamona Schrage, Anna-Lena Schmitz, Evelyn Gaffal, et al.
Pageof 16